BAX

BAXTER INTERNATIONAL INC

Apr 05 • 04:00PM ET

31.66

+0.62 (+2.00%)

Company Profile

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as ad ... read more

Full Time Employees 60,000

Phone 224 948 2000

Website https://www.baxter.com

CEO Mr. Jose E. Almeida

IPO Date 1981-10-27

Sector Healthcare

Industry Medical - Instruments & Supplies

Address One Baxter Parkway, Deerfield, IL 60015

Balance Sheet

Total Cash $2,294,000,000

Total Debt $10,309,000,000

Current Ratio 2.02

Quick Ratio 1.13

Profitability

Gross Margin 36.03%

Net Margin -4.71%

ROE -7.91%

ROA -2.63%

ROIC -2.23%

Balance Sheet

Total Cash $2,294,000,000

Total Debt $10,309,000,000

Current Ratio 2.02

Quick Ratio 1.13

Profitability

Gross Margin 36.03%

Net Margin -4.71%

ROE -7.91%

ROA -2.63%

ROIC -2.23%

Name	BAXTER INTERNATIONAL INC	Sector	Healthcare	Currency	USD	Relative Volume	1.26	Market Cap	14729
Current Ratio	1.36	Dividend / Share	1.04	EPS	-1.27	Revenue	10636000000	P/S	1.4
P/E	-22.7	Beta	0.28	Income	-649000000	Volume	5993808	Average Volume	4766070
Distance to 200DMA	-16.14%	200 DMA	34.33	50 DMA	33.27	ROA	-2.4	ROE	-8.5
Distance to 50DMA	-13.47%	Return 1Y	-31.73%	Return YTD	-0.78%	Forward PE		Qtly Growth YOY
Debt/Eq	2.69	P/B	2.1	Dividend Yield	3.6%	Net Margin	-6.1%	Payout Ratio	-81.9

Performance

52 Week Range -81.9%

Distance to 200DMA 1.83%

Day Change Percent $0.58

Performance Week $0.29

Performance Month $0.29

Performance Quarter 2024-08-30

Performance YTD $0.29

Performance Year $0.29

Performance Range

Day

$196

Current

Low: High:

Month

$196

Current

Low: High:

Month

$196

Current

Low: High:

Month

$196

Current

Low: High:

Month

$196

Current

Low: High:

Balance Sheet

Total Cash $1,420,000,000

Total Debt $13,194,000,000

Current Ratio 1.43%

Quick Ratio 0.51%

Profitability

Valuation

Price to Earnings -28.95

Price to Book 2.29

Price to Sales 1.36

Price to Free Cash Flow 61.63

Dividends

Payout Ratio -84.11%

Dividend Yield 2.91%

Dividend Amount $0.58

Last Dividend Pay Date 2024-08-30

Last Dividend Paid $0.29

Performance

52 Week Range -81.9%

Distance to 200DMA 1.83%

Day Change Percent $0.58

Performance Week $0.29

Performance Month $0.29

Performance Quarter 2024-08-30

Performance YTD $0.29

Performance Year $0.29

Company Profile

Full Time Employees 60,000

Phone 224 948 2000

Website https://www.baxter.com

CEO Mr. Jose E. Almeida

IPO Date 1981-10-27

Sector Healthcare

Address One Baxter Parkway, Deerfield, IL 60015

Histogram - Daily

Balance Sheet

Total Cash $1,420,000,000

Total Debt $13,194,000,000

Current Ratio 1.43%

Quick Ratio 0.51%

Profitability

Gross Margin 0.3810%

Net Margin 0.0080%

ROE 0.01%

ROA 0.00%

Company Profile

Full Time Employees 60,000

Phone 224 948 2000

Website https://www.baxter.com

CEO Mr. Jose E. Almeida

IPO Date 1981-10-27

Sector Healthcare

Address One Baxter Parkway, Deerfield, IL 60015

Monthly Win Rate

Balance Sheet (Multi-Column Example)

	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Cash & Short Term Investments	53,775.0	65,171.0	61,801.0	67,150.0	73,100.0	61,555.0	62,482.0	55,872.0
Receivables	59,306.0	66,243.0	43,172.0	41,150.0	50,102.0	60,985.0	39,186.0	35,899.0
Inventory	6,911.0	7,286.0	6,165.0	6,232.0	6,511.0	6,331.0	7,351.0	7,482.0

Latest News

The 'Goldilocks' Case For Baxter International

Baxter International's stock has been challenging to own for the past decade, initially due to high valuations and later due to execution concerns and an ugly acquisition. During the pandemic, health

2025-05-08 10:16:09 - seekingalpha.com

Baxter Declares Quarterly Dividend

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share o

2025-05-06 16:15:00 - businesswire.com

Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript

Baxter International Inc. (NYSE:BAX ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President and Chief Investor Relations Officer Brent Sh

2025-05-01 13:27:16 - seekingalpha.com

BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y

Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts.

2025-05-01 12:50:40 - zacks.com

Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Ju

On Thursday, Baxter International Inc. BAX reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.

2025-05-01 11:36:49 - benzinga.com

Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to

2025-05-01 10:35:58 - zacks.com

Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street es

2025-05-01 10:35:55 - zacks.com

Baxter tops quarterly estimates on strong demand for medical devices

Medical products maker Baxter International on Thursday beat Wall Street estimates for first-quarter revenue and profit, helped by the robust demand for its intravenous (IV) solutions and patient-moni

2025-05-01 09:13:02 - reuters.com

Baxter Reports First-Quarter 2025 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2025. “Our solid performance in the first quarter of 20

2025-05-01 07:15:00 - businesswire.com

MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK

This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.

2025-04-30 11:55:39 - zacks.com

Baxter to Present at Bank of America Securities 2025 Health Care Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Jo

2025-04-29 16:15:00 - businesswire.com

Will BAX's Q1 Earnings Improve Following Transformation Completion?

Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.

2025-04-28 14:20:34 - zacks.com

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Co

VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature st

2025-04-10 09:16:00 - businesswire.com

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Co

2025-04-10 09:15:00 - businesswire.com

Baxter to Host Annual Meeting of Stockholders in Virtual Format

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2025 Annual Meeting) in a virtual format on Tuesday,

2025-03-26 09:00:00 - businesswire.com

Baxter Stock Likely to Gain Following the Introduction of Voalte Linq

At the 2025 HIMSS Global Healthcare Conference, BAX unveils its Voalte Linq device, powered by Scotty assistant, a voice-activated technology.

2025-03-06 10:15:44 - zacks.com